Production of rIL-22 by engineered Lactobacillus reuteri can also ameliorate hepatic steatosis in mice with diet-induced obesity, as evidenced by reduced triglyceride levels and liver weight via the IL-22/STAT3/Reg3 cascade [94]. Here, IL22 is linked to Hepatic steatosis.